Siponimod tablets bulk supplier for pharma manufacturers

Siponimod Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 2 mg tablets

Reference Brands: Mayzent(US &EU)

Category: Multiple sclerosis

Siponimod tablets is available in Tablet and strengths such as 2 mg tablets. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Siponimod tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Siponimod tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Siponimod tablets, marketed as Mayzent, are approved in the US by the FDA and in the EU via EMA for treating active secondary progressive multiple sclerosis (SPMS). Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing details, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and manufacturing information, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring thorough compliance is essential for timely approval, safe use, and global availability of siponimod tablets, supporting optimal MS management worldwide.

Frequently Asked Questions

Yes, Siponimod tablets is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Siponimod tablets is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Lamotriginevdispersible Tablets

Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg

Form: Tablets(IR & ER)

Reference Brands: Lamictal, Lamictal XR(EU & US)

View Details
Tolterodine Tablets/ Capsules(Ir & Er)

Strength:
IR: 1 mg, 2 mg; ER: 2mg, 4 mg

Form: Tablets/ Capsules(IR & ER)

Reference Brands: Detrol, Detrol LA(US & EU)

View Details
Oxybutynin Tstransdermal Patch

Strength:
3.9 mg/24 hours

Form: transdermal patch

Reference Brands: Oxytrol, Oxytrol for Women(US & EU)

View Details
Oxybutynin Tablets

Strength:
IR: 5 mg, 10 mg; ER: 5 mg, 10 mg

Form: Tablet(IR & ER)

Reference Brands: Ditropan, Oxybutynin XL(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.